Daiwa Securities Group’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Hold |
1,369
| – | – | ﹤0.01% | 1267 |
|
|
2025
Q1 | $1K | Hold |
1,369
| – | – | ﹤0.01% | 1232 |
|
|
2024
Q4 | $1K | Hold |
1,369
| – | – | ﹤0.01% | 1256 |
|
|
2024
Q3 | $2K | Hold |
1,369
| – | – | ﹤0.01% | 1221 |
|
|
2024
Q2 | $2K | Buy |
1,369
+935
| +215% | +$1.37K | ﹤0.01% | 1244 |
|
|
2024
Q1 | $1K | Hold |
434
| – | – | ﹤0.01% | 1290 |
|
|
2023
Q4 | $1K | Hold |
434
| – | – | ﹤0.01% | 1290 |
|
|
2023
Q3 | $0 | Hold |
434
| – | – | ﹤0.01% | 1311 |
|
|
2023
Q2 | $1K | Hold |
434
| – | – | ﹤0.01% | 1273 |
|
|
2023
Q1 | $1K | Hold |
434
| – | – | ﹤0.01% | 1253 |
|
|
2022
Q4 | $1K | Hold |
434
| – | – | ﹤0.01% | 1269 |
|
|
2022
Q3 | $1K | Hold |
434
| – | – | ﹤0.01% | 1290 |
|
|
2022
Q2 | $1K | Hold |
434
| – | – | ﹤0.01% | 1286 |
|
|
2022
Q1 | $1K | Hold |
434
| – | – | ﹤0.01% | 1308 |
|
|
2021
Q4 | $2K | Buy |
+434
| New | +$2K | ﹤0.01% | 1279 |
|
|
2020
Q4 | – | Sell |
-583
| Closed | -$1K | – | 1277 |
|
|
2020
Q3 | $1K | Hold |
583
| – | – | ﹤0.01% | 1155 |
|
|
2020
Q2 | $1K | Hold |
583
| – | – | ﹤0.01% | 1171 |
|
|
2020
Q1 | $1K | Hold |
583
| – | – | ﹤0.01% | 1179 |
|
|
2019
Q4 | $2K | Hold |
583
| – | – | ﹤0.01% | 1150 |
|
|
2019
Q3 | $2K | Hold |
583
| – | – | ﹤0.01% | 1116 |
|
|
2019
Q2 | $4K | Hold |
583
| – | – | ﹤0.01% | 1099 |
|
|
2019
Q1 | $3K | Hold |
583
| – | – | ﹤0.01% | 1094 |
|
|
2018
Q4 | $4K | Hold |
583
| – | – | ﹤0.01% | 1060 |
|
|
2018
Q3 | $6K | Hold |
583
| – | – | ﹤0.01% | 1057 |
|
|
2018
Q2 | $7K | Hold |
583
| – | – | ﹤0.01% | 1060 |
|
|
2018
Q1 | $5K | Buy |
+583
| New | +$5K | ﹤0.01% | 1064 |
|